Document is current
Any future updates will be listed below
-
Authors
Weirauch, Tobias
Schüttfort, Gundolf
Vehreschild, Maria J. G. T.
-
Funding
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
- License Information
-
More Information
Article History
Received: 21 May 2024
Accepted: 6 November 2024
First Online: 2 December 2024
Declarations
:
: T.W. has nothing to disclose. G.S. received funding from Gilead Sciences and speaker fees from ViiV Healthcare, Bristol Meyer Squibb, MSD and Hormosan for participation in Advisory Boards, Data Safety and Montitoring Boards and for preparation of educational materials and lecturing fees. M.J.G.T.V. has received research grants from 3 M, Astellas Pharma, Biontech, DaVolterra, Evonik, Gilead Sciences, Glycom, Immunic, MaaT Pharma, Merck/MSD, Organobalance, Seres Therapeutics, Takeda Pharmaceutical and speaker fees and/or consulting fees from Astellas Pharma, Basilea, Bio-Mérieux, DaVolterra, Farmak International Holding GmbH, Ferring, Gilead Sciences, Immunic AG, MaaT Pharma, Merck/MSD, Pfizer, Roche, Organobalance, SocraTec R&D GmbH.
: The patient gave written informed consent.
: We received consent for submission and publication of the case report to the journal.
